[{"address1": "2265 Upper Middle Road East", "address2": "Suite 602", "city": "Oakville", "state": "ON", "zip": "L6H 0G5", "country": "Canada", "phone": "289 910 0850", "fax": "905 481 2394", "website": "https://www.cardiolrx.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.", "fullTimeEmployees": 18, "companyOfficers": [{"maxAge": 1, "name": "Mr. David G. Elsley MBA", "title": "President, CEO & Director", "fiscalYear": 2024, "totalPay": 579120, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher J. Waddick C.A., C.M.A., CPA, CMA, MBA", "title": "CFO, Corporate Secretary & Director", "fiscalYear": 2024, "totalPay": 226500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bernard  Lim B.Sc.", "title": "Chief Operating Officer", "fiscalYear": 2024, "totalPay": 396375, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew Warwick Hamer M.D.", "age": 62, "title": "Chief Medical Officer and Head of Research & Development", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 579203, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Trevor  Burns", "title": "Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John A. Geddes BSCPT, MBA", "title": "Vice President of Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 3, "compensationRisk": 10, "shareHolderRightsRisk": 3, "overallRisk": 9, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.44, "open": 1.42, "dayLow": 1.39, "dayHigh": 1.5, "regularMarketPreviousClose": 1.44, "regularMarketOpen": 1.42, "regularMarketDayLow": 1.39, "regularMarketDayHigh": 1.5, "payoutRatio": 0.0, "beta": 0.763, "forwardPE": -4.7096777, "volume": 176380, "regularMarketVolume": 176380, "averageVolume": 197457, "averageVolume10days": 286750, "averageDailyVolume10Day": 286750, "bid": 1.4, "ask": 1.51, "bidSize": 1, "askSize": 1, "marketCap": 120668560, "fiftyTwoWeekLow": 0.771, "fiftyTwoWeekHigh": 2.63, "fiftyDayAverage": 1.13304, "twoHundredDayAverage": 1.452635, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 95873560, "profitMargins": 0.0, "floatShares": 79599950, "sharesOutstanding": 82649696, "sharesShort": 1987533, "sharesShortPriorMonth": 2015728, "sharesShortPreviousMonthDate": 1745971200, "dateShortInterest": 1748563200, "sharesPercentSharesOut": 0.024, "heldPercentInsiders": 0.04348, "heldPercentInstitutions": 0.101660006, "shortRatio": 12.79, "shortPercentOfFloat": 0.025, "impliedSharesOutstanding": 85893000, "bookValue": 0.213, "priceToBook": 6.8544602, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -35785320, "trailingEps": -0.34, "forwardEps": -0.31, "enterpriseToEbitda": -2.385, "52WeekChange": -0.3363636, "SandP52WeekChange": 0.09203708, "quoteType": "EQUITY", "currentPrice": 1.46, "targetHighPrice": 10.220896, "targetLowPrice": 8.228407, "targetMeanPrice": 9.052536, "targetMedianPrice": 8.880421, "recommendationMean": 1.8, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 23292700, "totalCashPerShare": 0.282, "ebitda": -40190760, "totalDebt": 150660, "quickRatio": 3.05, "currentRatio": 3.261, "debtToEquity": 0.857, "returnOnAssets": -0.89032, "returnOnEquity": -1.9011, "freeCashflow": -13604821, "operatingCashflow": -25291840, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CAD", "symbol": "CRDL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1749856228, "regularMarketTime": 1749844800, "exchange": "NCM", "messageBoardId": "finmb_424954803", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 1.3888875, "regularMarketPrice": 1.46, "marketState": "CLOSED", "shortName": "Cardiol Therapeutics Inc.", "longName": "Cardiol Therapeutics Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1547562600000, "postMarketChangePercent": -1.36986, "postMarketPrice": 1.44, "postMarketChange": -0.02, "regularMarketChange": 0.01999998, "regularMarketDayRange": "1.39 - 1.5", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 197457, "fiftyTwoWeekLowChange": 0.689, "fiftyTwoWeekLowChangePercent": 0.8936446, "fiftyTwoWeekRange": "0.771 - 2.63", "fiftyTwoWeekHighChange": -1.1700001, "fiftyTwoWeekHighChangePercent": -0.44486693, "fiftyTwoWeekChangePercent": -33.63636, "earningsTimestamp": 1747252800, "earningsTimestampStart": 1754942400, "earningsTimestampEnd": 1755288000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.34, "epsForward": -0.31, "epsCurrentYear": -0.5, "priceEpsCurrentYear": -2.92, "fiftyDayAverageChange": 0.3269601, "fiftyDayAverageChangePercent": 0.28856888, "twoHundredDayAverageChange": 0.0073649883, "twoHundredDayAverageChangePercent": 0.0050700884, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-08-10", "averageAnalystRating": "1.8 - Buy", "cryptoTradeable": false, "displayName": "Cardiol Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-06-14"}]